Last reviewed · How we verify
Type 2 Diabetes Mellitus Treatment Adjunct
Approved treatments
- Parlodel · Esjay Pharma
- Byetta · AstraZeneca
Byetta works by mimicking the action of a natural hormone in the body to regulate blood sugar levels. - Welchol · Cosette
Welchol works by binding to bile acids in the gut, reducing their reabsorption and increasing their excretion, which in turn lowers cholesterol levels and improves blood sugar control. - Byetta · AstraZeneca
Byetta works by activating the glucagon-like peptide 1 receptor, which helps regulate blood sugar levels. - Symlin · Astrazeneca Ab
- Bydureon · Phoenix VA Health Care System
- Welchol · Daiichi Sankyo
- Bromocriptin · University Hospital, Bonn
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Type 2 Diabetes Mellitus Treatment Adjunct patent landscape — cliff calendar, originator estates, attackable patents
- Type 2 Diabetes Mellitus Treatment Adjunct treatment landscape brief
- Type 2 Diabetes Mellitus Treatment Adjunct treatment updates RSS
Frequently asked questions about Type 2 Diabetes Mellitus Treatment Adjunct
What drugs treat Type 2 Diabetes Mellitus Treatment Adjunct?
Tracked treatments include Parlodel, Byetta, Welchol, Symlin, Bydureon, Bromocriptin.
What is the treatment for Type 2 Diabetes Mellitus Treatment Adjunct?
Standard treatment for Type 2 Diabetes Mellitus Treatment Adjunct includes Parlodel, Byetta, Welchol, Symlin, Bydureon. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Type 2 Diabetes Mellitus Treatment Adjunct patent cliff · Type 2 Diabetes Mellitus Treatment Adjunct CI report
- Treatment: Parlodel · Esjay Pharma
- Treatment: Byetta · AstraZeneca
- Treatment: Welchol · Cosette
- Treatment: Byetta · AstraZeneca
- Treatment: Symlin · Astrazeneca Ab
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing